Jamie Dimon, CEO of JPMorgan Chase & Co, recently bought 500,000 shares of the company's stock, a source says.» Read More
Frustrated Microsoft owners are taking to the options market. Here's why.
CNBC's Jim Cramer said investors looking to own a blue-chip stock should consider investing in McDonald's, and here's why.
The strong jobs report released Friday may have set up a winning short-term trade in certain sectors and slices of the stock market.
S&P futures moved almost 10 points on the April nonfarm payroll report of 223,000, essentially in line with expectations of 224,000.
"My view is we're going to have a lot of choppiness without a lot of trend for a while," Nuveen's Bob Doll tells CNBC.
Some of the names on the move ahead of the open.
A research firm believes crude oil prices could erase half of their losses from the peak last year.
A phone call turns historic when a “Mad Money” fan stakes a claim to host Jim Cramer.
The monthly jobs report will indicate whether the economy is bouncing back in the second quarter. But just how good of an indication will it be?
The sport tracker company Fitbit just filed for an IPO of up to a $100 million. The company will trade on the NYSE under the ticker FIT.
Jim Cramer sees the market is unpredictable, so he went off the charts to reveal one group that has all the stars aligned for success.
The "Fast Money" traders give their final trades of the day.
Today's lowest mortgage rates and fees go to borrowers with credit scores of 740 or higher.
Jim Cramer sees that things are looking up across the pond and has the perfect way to play it.
The online business review company is considering a sale as its stock has struggled this year, according to reports.
Check out the companies making headlines after the bell Thursday: CBS, Monster Beverage, Rocket Fuel & more.
Hedge and private equity funds are filling the void left by more cautious banks in lending to small and medium-size business.
Apple's deft debt offering highlights the role that low rates have played in supporting the market.
If Tesla were to raise over a billion dollars in this market, bears and critics would be hard pressed, CNBC's Jim Cramer says.
The hedge fund manager who has already made a killing betting against biotech company MannKind now says the stock will soon be worthless.